InVivoMAb Anti-Human ApoC3 Antibody (Iv0249) from ProteoGenix; catalogue ARO-A12964; research use only.
Know who made it. See the evidence. Buy through one marketplace.
InVivoMAb Anti-Human ApoC3 Antibody (Iv0249) is a ProteoGenix primary antibody supplied under catalogue number ARO-A12964 for research use only.
Target: APOC3; Host: Human; Clonality: Monoclonal Antibody; Buffer: 0.01M PBS, pH 7.4.; Reactivity: Human.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
APOC3 (apolipoprotein C3) encodes apolipoprotein C-III (ApoC-III), a component of triglyceride-rich lipoproteins including VLDL and chylomicrons and also of HDL. APOC3 is a key regulator of triglyceride homeostasis through effects on lipoprotein production, lipolysis and remnant clearance.
Biological function: Apolipoprotein C-III regulates triglyceride-rich lipoprotein metabolism at several steps. NCBI and reviewed UniProt describe APOC3 as promoting hepatic VLDL1 assembly and secretion, inhibiting lipoprotein lipase-mediated triglyceride hydrolysis, and delaying hepatic clearance of triglyceride-rich lipoprotein remnants.
